Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.

Heike Wulff1, Hans-Günther Knaus, Michael Pennington

  • 1Department of Medical Pharmacology and Toxicology, University of California, Davis, CA 95616, USA. hwuff@ucdavis.edu

Journal of Immunology (Baltimore, Md. : 1950)
|July 9, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium Cations.

Angewandte Chemie (International ed. in English)·2026
Same author

Translating Science into Practice Using University-State Government Partnerships: The EPIS Model.

Prevention science : the official journal of the Society for Prevention Research·2026
Same author

Structural basis for the subtype-selective activation of K<sub>Ca</sub>3.1 channels.

Structure (London, England : 1993)·2026
Same author

Kv1.3 as an upstream regulator of oxidative stress-mediated neuroinflammation following organic dust exposure in murine <i>in vitro</i>, <i>ex vivo</i>, and <i>in vivo</i> models.

Frontiers in toxicology·2026
Same author

New mitochondrial K<sub>V</sub>1.3 conjugates are potent and specific inducers of apoptosis in cancer models.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Kv1.3 inhibition alleviates neuropathology via neuroinflammatory and resilience pathways in a mouse model of Aβ pathology.

bioRxiv : the preprint server for biology·2026

Human B cell differentiation involves a switch in potassium channel expression, impacting proliferation. Naive and memory B cells show distinct channel profiles, suggesting targeted therapies for immune disorders.

Area of Science:

  • Immunology
  • Cell Biology
  • Channel Physiology

Background:

  • B cell differentiation from naive to memory states involves significant cellular changes.
  • Potassium channels play crucial roles in lymphocyte activation and function.
  • Understanding ion channel dynamics is key to modulating immune responses.

Purpose of the Study:

  • To investigate the differential expression and function of potassium channels (Kv1.3 and IKCa1) during human B cell differentiation.
  • To correlate potassium channel expression patterns with B cell proliferation and activation states.
  • To explore the therapeutic potential of specific potassium channel inhibitors in manipulating B cell subsets.

Main Methods:

  • Whole-cell patch-clamp electrophysiology to measure ion channel activity.

Related Experiment Videos

  • Fluorescence microscopy and flow cytometry for cell surface marker analysis and channel expression quantification.
  • Pharmacological inhibition using specific Kv1.3 and IKCa1 blockers (Stichodactyla helianthus toxin and TRAM-34) to assess proliferation effects.

    • Main Results:

    • Naive and IgD(+)CD27(+) memory B cells exhibit low basal Kv1.3 and IKCa1, with a 45-fold increase in IKCa1 upon activation.
    • Class-switched memory B cells display high constitutive Kv1.3 expression, maintained post-activation.
    • IKCa1 inhibition suppressed naive/IgD(+)CD27(+) B cell proliferation, while Kv1.3 inhibition affected class-switched memory B cells, mirroring T cell responses.

    Conclusions:

    • Human B cell differentiation is characterized by a dynamic shift in potassium channel expression, particularly Kv1.3 and IKCa1.
    • These distinct channel phenotypes dictate the differential sensitivity of B cell subsets to specific ion channel inhibitors.
    • Targeted inhibition of Kv1.3 or IKCa1 presents a potential strategy for selective immunomodulation in various immunological disorders.